Evaluation of the effects of propolis- echinacea supplementation on Chronic fatigue syndrome and quality of life in lung cancer patients (NSCLC) consuming Pemetrexed
Phase 3
Not yet recruiting
- Conditions
- on-small cell lung cancer (NSCLC).Malignant neoplasm of unspecified part of bronchus or lungC34.9
- Registration Number
- IRCT20151227025726N33
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Lung cancer patients (NSCLC) consuming Pemetrexed
Exclusion Criteria
Patients who are allergic to medicine
Patients with hypothyroidism
Patients using hypnotics and neuroleptics
Patients addicted to drugs
Suffering from underlying nerve disorders
Patients who need surgery
Pregnant and lactating
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life score based on EQ-5D-3L questionnaire. Timepoint: Measuring the quality of life based on the EQ-5D-3L questionnaire on days 0 and 28. Method of measurement: EQ-5D-3L questionnaire.;Fatigue complication score based on BFI questionnaire. Timepoint: Measurement of fatigue complication score based on BFI questionnaire on days 0-7-14-21-28. Method of measurement: BFI questionnaire.
- Secondary Outcome Measures
Name Time Method Hospitalization rate. Timepoint: Before intervention and one month after the end of intervention. Method of measurement: Patient’s record.;Rate of infection. Timepoint: Before intervention and one month after the end of intervention. Method of measurement: Patient’s record.